查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597836

TDM試劑組市場：按藥物類型、ELISA 類型、適應症、機制、樣本類型和最終用戶 - 2025-2030 年全球預測

TDM Reagent Kit Market by Drug Type (Amikacin, Carbamazepine, Gentamicin), ELISA Type (Antibody Screening - Qualitative, Antibody Screening - Quantitative, Free Drug), Indication, Mechanism, Sample Type, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年TDM試劑組市值為18.9億美元，預計到2024年將達到21.5億美元，複合年成長率為15.14%，到2030年將達到50.8億美元。

TDM（治療藥物監測）試劑組市場專注於透過最佳化個別藥物劑量來改善患者的治療效果。這涉及使用專門的試劑來定量測量患者血液中特定藥物的濃度，個人化治療並最大限度地減少副作用。隨著個人化醫療的發展勢頭，對 TDM套件的需求不斷增加，特別是在腫瘤學、精神病學和器官移植等關鍵治療領域。這些套件主要用於醫院、診所和實驗室，以確保有效劑量並提高病人安全。慢性疾病患者數量的增加、對個人化藥物治療的日益依賴以及藥物基因組學的進步推動了市場成長。生物感測器技術和人工智慧的最新趨勢提供了潛在的機會。透過促進即時監控和預測分析，這些進步將帶來更加動態和響應更快的 TDM 方法，簡化與日常實踐的整合並擴大可訪問性。然而，高成本、嚴格的監管要求以及需要廣泛驗證等挑戰限制了這些套件的快速採用。此外，藥物代謝的個體差異需要針對特定區域的研究和驗證，這為市場的快速擴張造成了障礙。潛在的創新領域包括開發具有成本效益的生物感測器和行動測試方法，這些方法可在非臨床環境和偏遠地區進行廣泛的應用。將人工智慧整合到劑量預測演算法中的轉變也可能透過擴大精準醫療的範圍來推動市場成長。數位醫療保健的發展透過資料分析和遠端醫療增加了新的價值創造層，以最佳化藥物監測流程。為了利用這些機會，相關人員應專注於與高科技公司的策略合作夥伴關係，投資於感測器技術的持續研究和開發，並積極開展宣傳工作以克服監管挑戰。趨勢保持治療性介入。

主要市場統計
基準年[2023] 18.9億美元
預測年份 [2024] 21.5億美元
預測年份 [2030] 50.8億美元
複合年成長率（%） 15.14%

市場動態：揭示快速發展的 TDM試劑組市場的關鍵市場洞察

TDM試劑組市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 自動分析儀試劑測定血液藥物濃度的用途
    • 液體即用型試劑在治療自體免疫疾病的優勢
    • 由於感染疾病的增加，TDM試劑組的前景不斷擴大
  • 市場限制因素
    • 臨床服務滲透有限
  • 市場機會
    • 世界各地診斷和臨床實驗室的成長
    • 增加研發資金以開發先進的 TDM試劑組
  • 市場挑戰
    • TDM 檢查的操作限制

波特五力：駕馭 TDM試劑組市場的策略工具

波特五力框架是了解 TDM試劑組市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 TDM試劑組市場的外部影響

外部宏觀環境因素在塑造 TDM試劑組市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解TDM試劑組市場的競爭狀況

TDM試劑組市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 TDM試劑組市場供應商的績效評估

FPNV定位矩陣是評估TDM試劑組市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃 TDM試劑組市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對 TDM試劑組市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 使用自動分析儀試劑測量藥物的血液濃度
      • 液體試劑在治療自體免疫疾病的優勢
      • 隨著感染疾病的增加，TDM試劑組的前景廣闊
    • 抑制因素
      • 臨床服務滲透有限
    • 機會
      • 世界各地診斷和臨床實驗室的成長
      • 增加先進開發 TDM試劑組的研發資金
    • 任務
      • TDM 測試的操作限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依藥物類型分類的TDM試劑組市場

  • Amikacin
  • Carbamazepine
  • 慶大霉素
  • 拉莫三嗪
  • 納帕
  • Phenobarbital
  • 苯妥英
  • 普魯卡因醯胺
  • Teicoplanin
  • 茶鹼
  • 妥布黴素
  • 萬古黴素

第 7 章 ELISA 類型的 TDM試劑組市場

  • 抗體篩檢- 定性
  • 抗體篩檢-定量
  • 免費醫療

第8章 TDM試劑組市場（按適應症）

  • 抗過敏/氣喘
  • 抗癌藥
  • 發炎（藥
  • 抗TNFa
  • 查核點抑制劑
  • 免疫刺激
  • 肥胖
  • 骨質疏鬆症
  • 濕性AMD

第9章 TDM試劑組市場：按機制

  • 校準器
  • 控制
  • 試劑

第 10 章按樣品類型分類的 TDM試劑組市場

  • 電漿
  • 血清

第 11 章 TDM試劑組市場：依最終用戶分類

  • 臨床/診斷中心
  • 醫院

第12章美洲TDM試劑組市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區TDM試劑組市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東和非洲TDM試劑組市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Aalto Scientific, Ltd.
  • Abbott Laboratories Inc.
  • ApDia Group
  • ARK Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BioTeZ Berlin-Buch GmbH
  • Eagle Biosciences, Inc.
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols SA
  • Immundiagnostik AG
  • Randox Laboratories Ltd.
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
Product Code: MRR-335201F2E53B

The TDM Reagent Kit Market was valued at USD 1.89 billion in 2023, expected to reach USD 2.15 billion in 2024, and is projected to grow at a CAGR of 15.14%, to USD 5.08 billion by 2030.

The TDM (Therapeutic Drug Monitoring) Reagent Kit market is primarily focused on improving patient outcomes by optimizing individual drug dosages. It encompasses the use of specialized reagents for quantitatively measuring the concentration of specific drugs in patients' blood to personalize therapy and minimize adverse effects. As personalized medicine gains momentum, the necessity for TDM kits escalates, particularly in critical therapeutic areas like oncology, psychiatry, and organ transplantation. These kits are predominantly used by hospitals, clinics, and research labs to ensure effective dosages and enhance patient safety. Market growth is driven by rising chronic illness cases, increasing reliance on personalized medication regimes, and advances in pharmacogenomics. Recent developments in biosensor technology and artificial intelligence offer potential opportunities. By facilitating real-time monitoring and predictive analytics, these advancements can lead to more dynamic and responsive TDM approaches, simplifying integration into everyday practice and broadening accessibility. However, challenges such as high costs, strict regulatory requirements, and the need for extensive validation limit the rapid adoption of these kits. Additionally, variations in drug metabolism among different populations require region-specific research and validation, posing hurdles for quick market expansion. Potential areas of innovation include the development of cost-efficient biosensors and mobile-enabled testing methodologies that allow broader application in non-clinical settings and remote areas. A shift towards integrating AI for predictive dosage algorithms can also propel market growth by enhancing precision medicine's scope. The evolving landscape of digital healthcare adds another layer of value creation through data analytics and telemedicine, optimizing drug-monitoring processes. To capitalize on these opportunities, stakeholders should focus on strategic collaborations with tech firms, invest in ongoing R&D for sensor technologies, and actively engage in policy advocacy to overcome regulatory challenges, ensuring alignment with global healthcare trends fostering safer, targeted therapeutic interventions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.89 billion
Estimated Year [2024] USD 2.15 billion
Forecast Year [2030] USD 5.08 billion
CAGR (%) 15.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving TDM Reagent Kit Market

The TDM Reagent Kit Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Use of reagents for automated analyzers to measure blood concentrations of drugs
    • Benefits of liquid-ready-to-use reagents in the treatment of autoimmune diseases
    • Growing prospect of TDM reagent kits with the growth of infectious diseases
  • Market Restraints
    • Limited penetration in clinical services
  • Market Opportunities
    • Growth in diagnostics & clinical laboratories worldwide
    • Rising R&D funding for developing advanced TDM reagent kit
  • Market Challenges
    • Operational limitations with TDM tests

Porter's Five Forces: A Strategic Tool for Navigating the TDM Reagent Kit Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the TDM Reagent Kit Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the TDM Reagent Kit Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the TDM Reagent Kit Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the TDM Reagent Kit Market

A detailed market share analysis in the TDM Reagent Kit Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the TDM Reagent Kit Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the TDM Reagent Kit Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the TDM Reagent Kit Market

A strategic analysis of the TDM Reagent Kit Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the TDM Reagent Kit Market, highlighting leading vendors and their innovative profiles. These include Aalto Scientific, Ltd., Abbott Laboratories Inc., ApDia Group, ARK Diagnostics, Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, BioTeZ Berlin-Buch GmbH, Eagle Biosciences, Inc., Exagen Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Immundiagnostik AG, Randox Laboratories Ltd., Sekisui Medical Co., Ltd., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the TDM Reagent Kit Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Amikacin, Carbamazepine, Gentamicin, Lamotrigine, NAPA, Phenobarbital, Phenytoin, Procainamide, Teicoplanin, Theophylline, Tobramycin, and Vancomycin.
  • Based on ELISA Type, market is studied across Antibody Screening - Qualitative, Antibody Screening - Quantitative, and Free Drug.
  • Based on Indication, market is studied across Anti-Allergy & Asthma, Anti-Cancer, Anti-Inflammatory, Anti-TNFa, Checkpoint Inhibitors, Immune Stimulation, Obesity, Osteoporosis, and Wet AMD.
  • Based on Mechanism, market is studied across Calibrator, Control, and Reagent.
  • Based on Sample Type, market is studied across Plasma and Serum.
  • Based on End-Users, market is studied across Clinical & Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Use of reagents for automated analyzers to measure blood concentrations of drugs
      • 5.1.1.2. Benefits of liquid-ready-to-use reagents in the treatment of autoimmune diseases
      • 5.1.1.3. Growing prospect of TDM reagent kits with the growth of infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Limited penetration in clinical services
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth in diagnostics & clinical laboratories worldwide
      • 5.1.3.2. Rising R&D funding for developing advanced TDM reagent kit
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations with TDM tests
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. TDM Reagent Kit Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Amikacin
  • 6.3. Carbamazepine
  • 6.4. Gentamicin
  • 6.5. Lamotrigine
  • 6.6. NAPA
  • 6.7. Phenobarbital
  • 6.8. Phenytoin
  • 6.9. Procainamide
  • 6.10. Teicoplanin
  • 6.11. Theophylline
  • 6.12. Tobramycin
  • 6.13. Vancomycin

7. TDM Reagent Kit Market, by ELISA Type

  • 7.1. Introduction
  • 7.2. Antibody Screening - Qualitative
  • 7.3. Antibody Screening - Quantitative
  • 7.4. Free Drug

8. TDM Reagent Kit Market, by Indication

  • 8.1. Introduction
  • 8.2. Anti-Allergy & Asthma
  • 8.3. Anti-Cancer
  • 8.4. Anti-Inflammatory
  • 8.5. Anti-TNFa
  • 8.6. Checkpoint Inhibitors
  • 8.7. Immune Stimulation
  • 8.8. Obesity
  • 8.9. Osteoporosis
  • 8.10. Wet AMD

9. TDM Reagent Kit Market, by Mechanism

  • 9.1. Introduction
  • 9.2. Calibrator
  • 9.3. Control
  • 9.4. Reagent

10. TDM Reagent Kit Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Plasma
  • 10.3. Serum

11. TDM Reagent Kit Market, by End-Users

  • 11.1. Introduction
  • 11.2. Clinical & Diagnostic Centers
  • 11.3. Hospitals

12. Americas TDM Reagent Kit Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific TDM Reagent Kit Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa TDM Reagent Kit Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aalto Scientific, Ltd.
  • 2. Abbott Laboratories Inc.
  • 3. ApDia Group
  • 4. ARK Diagnostics, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. BioTeZ Berlin-Buch GmbH
  • 8. Eagle Biosciences, Inc.
  • 9. Exagen Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Grifols S.A.
  • 12. Immundiagnostik AG
  • 13. Randox Laboratories Ltd.
  • 14. Sekisui Medical Co., Ltd.
  • 15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. TDM REAGENT KIT MARKET RESEARCH PROCESS
  • FIGURE 2. TDM REAGENT KIT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TDM REAGENT KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TDM REAGENT KIT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. TDM REAGENT KIT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. TDM REAGENT KIT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TDM REAGENT KIT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TDM REAGENT KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TDM REAGENT KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TDM REAGENT KIT MARKET DYNAMICS
  • TABLE 7. GLOBAL TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TDM REAGENT KIT MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TDM REAGENT KIT MARKET SIZE, BY CARBAMAZEPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TDM REAGENT KIT MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TDM REAGENT KIT MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TDM REAGENT KIT MARKET SIZE, BY NAPA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TDM REAGENT KIT MARKET SIZE, BY PHENOBARBITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TDM REAGENT KIT MARKET SIZE, BY PHENYTOIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TDM REAGENT KIT MARKET SIZE, BY PROCAINAMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TDM REAGENT KIT MARKET SIZE, BY TEICOPLANIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TDM REAGENT KIT MARKET SIZE, BY THEOPHYLLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TDM REAGENT KIT MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TDM REAGENT KIT MARKET SIZE, BY VANCOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ANTIBODY SCREENING - QUALITATIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ANTIBODY SCREENING - QUANTITATIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TDM REAGENT KIT MARKET SIZE, BY FREE DRUG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ANTI-ALLERGY & ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ANTI-CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TDM REAGENT KIT MARKET SIZE, BY ANTI-TNFA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TDM REAGENT KIT MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TDM REAGENT KIT MARKET SIZE, BY IMMUNE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TDM REAGENT KIT MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TDM REAGENT KIT MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TDM REAGENT KIT MARKET SIZE, BY WET AMD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL TDM REAGENT KIT MARKET SIZE, BY CALIBRATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL TDM REAGENT KIT MARKET SIZE, BY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL TDM REAGENT KIT MARKET SIZE, BY REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL TDM REAGENT KIT MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL TDM REAGENT KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL TDM REAGENT KIT MARKET SIZE, BY CLINICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL TDM REAGENT KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES TDM REAGENT KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA TDM REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. DENMARK TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. DENMARK TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. DENMARK TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. EGYPT TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. EGYPT TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 178. EGYPT TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. EGYPT TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. FINLAND TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. FINLAND TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 184. FINLAND TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. FINLAND TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. FRANCE TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. FRANCE TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 190. FRANCE TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. FRANCE TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. GERMANY TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. GERMANY TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 196. GERMANY TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. GERMANY TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. ISRAEL TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. ISRAEL TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 202. ISRAEL TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. ISRAEL TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. ITALY TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. ITALY TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 208. ITALY TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. ITALY TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NETHERLANDS TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 214. NETHERLANDS TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. NIGERIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. NIGERIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 220. NIGERIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. NIGERIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. NORWAY TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. NORWAY TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 226. NORWAY TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. NORWAY TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. POLAND TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. POLAND TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 232. POLAND TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. POLAND TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. QATAR TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. QATAR TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 238. QATAR TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. QATAR TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. RUSSIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. RUSSIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 244. RUSSIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. RUSSIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SAUDI ARABIA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 250. SAUDI ARABIA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH AFRICA TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH AFRICA TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SPAIN TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SPAIN TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 262. SPAIN TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SPAIN TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. SWEDEN TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. SWEDEN TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 268. SWEDEN TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. SWEDEN TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. SWITZERLAND TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 274. SWITZERLAND TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. TURKEY TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. TURKEY TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 280. TURKEY TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. TURKEY TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM TDM REAGENT KIT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM TDM REAGENT KIT MARKET SIZE, BY ELISA TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. UNITED KINGDOM TDM REAGENT KIT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM TDM REAGENT KIT MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 292. UNITED KINGDOM TDM REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM TDM REAGENT KIT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 294. TDM REAGENT KIT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 295. TDM REAGENT KIT MARKET, FPNV POSITIONING MATRIX, 2023